Prevention

Resource
February 12, 2019

Professor Quarraisha Abdool Karim is one of the world’s leading AIDS researchers and has made pioneering contributions to understanding the HIV epidemic in young people, especially among young women.

Event
February 12, 2019

Join the Population Council, International Rectal Microbicide Advocates (IRMA) 

Event
February 12, 2019

Join us for the OPTIONS webinar on the PrEP Communications Accelerator—an interactive tool that assists in the development of a de

Resource
February 5, 2019

The PrEP Costing Guidelines provide a framework for estimating the cost of providing pre-exposure prophylaxis (PrEP), which is the use of antiretroviral (ARV) drugs for preventing the acquisition of HIV infection.

News
February 5, 2019
Researchers borrow from behavioural economics to understand what women in sub-Saharan Africa really want from a pre-exposure prophylaxis (PrEP) product.
Resource
February 5, 2019

Video recording of the AIDS Research Advisory Committee meeting, which took place January 28, 2019.

Resource
February 5, 2019

This seven-module training package contains a library of slides for health care providers who are providing oral PrEP to adolescent girls and young women.

Resource
February 5, 2019

Update on recommendations on antiretroviral regimens for treating and preventing HIV infection: In 2016, WHO published the consolidated guidelines on the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and recommended tenofovir disoproxil fumarate (TDF

Resource
February 5, 2019

The amount of HIV in your body fluids is called your viral load. Effective HIV treatment (antiretroviral therapy) suppresses the amount of HIV in your body fluids to the point where standard tests are unable to detect any HIV, or can only find a tiny trace. Doctors call this ‘virological suppress

eToolkit
February 4, 2019

The OPTIONS Consortium, with work led by FSG, recently created the Plan 4 PrEP tool to support national planning for oral PrEP rollout.